SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-001691
Filing Date
2014-03-03
Accepted
2014-03-03 16:39:16
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2218387z10-k.htm 10-K 1649387
2 EX-10.13 a2218387zex-10_13.htm EX-10.13 1021791
3 EX-23.1 a2218387zex-23_1.htm EX-23.1 3396
4 EX-31.1 a2218387zex-31_1.htm EX-31.1 8094
5 EX-31.2 a2218387zex-31_2.htm EX-31.2 8106
6 EX-32 a2218387zex-32.htm EX-32 8869
13 G198973.JPG g198973.jpg GRAPHIC 70041
14 G959266.JPG g959266.jpg GRAPHIC 40961
  Complete submission text file 0001047469-14-001691.txt   13765744

Data Files

Seq Description Document Type Size
7 EX-101.INS thrx-20131231.xml EX-101.INS 1858532
8 EX-101.SCH thrx-20131231.xsd EX-101.SCH 96959
9 EX-101.CAL thrx-20131231_cal.xml EX-101.CAL 91872
10 EX-101.LAB thrx-20131231_lab.xml EX-101.LAB 1560021
11 EX-101.PRE thrx-20131231_pre.xml EX-101.PRE 813717
12 EX-101.DEF thrx-20131231_def.xml EX-101.DEF 596153
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 14660863
SIC: 2834 Pharmaceutical Preparations